Evonik posts lower sales and earnings, readies IPO

Evonik Industries reported a 6% drop in fourth-quarter Ebitda, to €492 million ($641.7 million), on 2% lower sales, to €3.27 billion, attributing the decline to destocking by customers and economic weakness. Net income was 86% higher, to €276 million, mainly because of tax effects....

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers